FdaApplication
ANDA 220493
Identifiers
- fda_app_no: ANDA220493
Properties
| Property | Value |
|---|---|
| applicant_name | ADAPTIS |
| application_type | ANDA |
| approval_date | 2026-04-22 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE;INJECTION |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE;INJECTION |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE;INJECTION |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE;INJECTION |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE;INJECTION |
5 products